Münster, Pamela: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer

Chien, A. Jo, Duralde, Erin, Hwang, Richard, Tsung, Karen, Kao, Chia-Ning, Rugo, Hope S., Melisko, Michelle E., Esserman, Laura J., Munster, Pamela N., Cedars, Marcelle, Kerlikowske, Karla, McCulloch,

Journal:

Breast Cancer Research and Treatment

Year:

2015

Language:

english

File:

PDF, 603 KB

english, 2015

2

A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells

Gabriela Chiosis, Merna N Timaul, Brian Lucas, Pamela N Munster, Fuzhong F Zheng, Laura Sepp-Lorenzino, Neal Rosen

Journal:

Chemistry & Biology

Year:

2001

Language:

english

File:

PDF, 931 KB

english, 2001

3

Activated Stat-3 in Melanoma

Messina, Jane L., Yu, Hua, Riker, Adam I., Munster, Pamela N., Jove, Richard L., Daud, Adil I.

Journal:

Year:

2008

Language:

english

File:

PDF, 532 KB

english, 2008

4

Phase I Study of CC-486 Alone and in Combination With Carboplatin or nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors

Von Hoff, Daniel D., Rasco, Drew W, Heath, Elisabeth I, Munster, Pamela N, Schellens, Jan H.M., Isambert, Nicolas, Le Tourneau, Christophe, O'Neil, Bert H., Mathijssen, Ron HJ, Lopez-Martin, Jose A.,

Journal:

Clinical Cancer Research

Year:

2018

Language:

english

File:

PDF, 1.53 MB

english, 2018

5

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

Munster, Pamela, Krop, Ian E., LoRusso, Patricia, Ma, Cynthia, Siegel, Barry A., Shields, Anthony F., Molnár, István, Wickham, Thomas J., Reynolds, Joseph, Campbell, Karen, Hendriks, Bart S., Adiwijay

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 1.17 MB

english, 2018

6

Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies

Katherine A. Rauen, Anuradha Banerjee, W. Robert Bishop, Jennifer O. Lauchle, Frank McCormick, Martin McMahon, Teri Melese, Pamela N. Munster, Sorena Nadaf, Roger J. Packer, Judith Sebolt-Leopold, Dav

Journal:

American Journal of Medical Genetics Part C: Seminars in Medical Genetics

Year:

2011

Language:

english

File:

PDF, 182 KB

english, 2011

7

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma

Kristine A. Donovan, Brent J. Small, Michael A. Andrykowski, Frederick A. Schmitt, Pamela Munster, Paul B. Jacobsen

Journal:

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

8

Fatigue after treatment for early stage breast cancer : A controlled comparison

Paul B. Jacobsen, Kristine A. Donovan, Brent J. Small, Heather S. Jim, Pamela N. Munster, Michael A. Andrykowski

Journal:

Year:

2007

Language:

english

File:

PDF, 105 KB

english, 2007

9

Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response

Stacy Moulder, Nickola Valkov, Anthony Neuger, Jimin Choi, Ji Hyun Lee, Susan Minton, Pamela Munster, Jana Gump, Mira Lacevic, Richard Lush, Dan Sullivan

Journal:

Year:

2008

Language:

english

File:

PDF, 152 KB

english, 2008

10

Cognitive functioning in breast cancer survivors: A controlled comparison

Heather S. L. Jim, Kristine A. Donovan, Brent J. Small, Michael A. Andrykowski, Pamela N. Munster, Paul B. Jacobsen

Journal:

Year:

2009

Language:

english

File:

PDF, 136 KB

english, 2009

11

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

Douglas C. Marchion, Elona Bicaku, Adil I. Daud, Victoria Richon, Daniel M. Sullivan, Pamela N. Munster

Journal:

Journal of Cellular Biochemistry

Year:

2004

Language:

english

File:

PDF, 469 KB

english, 2004

12

PURIFICATION AND CHARACTERIZATION OF A NOVEL 35-kDa PROTEIN FROM TRANSFORMED CARDIOMYOCYTES

Sundararaman Chandrasekhar, Pamela N Münster, William A Henzel, Adil I Daud

Journal:

Cell Biology International

Year:

1999

Language:

english

File:

PDF, 640 KB

english, 1999

13

Effects of phorbol ester on gap junctions of neonatal rat heart cells

Pamela N. Münster, Robert Weingart

Journal:

Pflügers Archiv European Journal of Physiology

Year:

1993

Language:

english

File:

PDF, 824 KB

english, 1993

14

Physical symptoms/side effects during breast cancer treatment predict posttreatment distress

Heather S. Jim, Michael A. Andrykowski, Pamela N. Munster, Paul B. Jacobsen

Journal:

Annals of Behavioral Medicine

Year:

2007

Language:

english

File:

PDF, 124 KB

english, 2007

15

Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety

Feng Guo, Stephen P. Letrent, Pamela N. Munster, Carolyn D. Britten, Karen Gelmon, Anthony W. Tolcher, Amarnath Sharma

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2008

Language:

english

File:

PDF, 382 KB

english, 2008

16

Exploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach

Clement K. Gwede, Brent J. Small, Pamela N. Munster, Michael A. Andrykowski, Paul B. Jacobsen

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 159 KB

english, 2008

17

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Scott Thomas, Kenneth T. Thurn, Elona Biçaku, Douglas C. Marchion, Pamela N. Münster

Journal:

Breast Cancer Research and Treatment

Year:

2011

Language:

english

File:

PDF, 1.93 MB

english, 2011

18

Discussion of fertility preservation with newly diagnosed patients: oncologists’ views

Gwendolyn P. Quinn, Susan T. Vadaparampil, Clement K. Gwede, Cheryl Miree, Lindsey M. King, Heather B. Clayton, Crystal Wilson, Pamela Munster

Journal:

Journal of Cancer Survivorship

Year:

2007

Language:

english

File:

PDF, 172 KB

english, 2007

19

New drugs in gynecologic cancer

Adil Daud, Pamela Munster, David R. Spriggs

Journal:

Current Treatment Options in Oncology

Year:

2001

Language:

english

File:

PDF, 263 KB

english, 2001

20

Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2

Basso, Andrea D, Solit, David B, Munster, Pamela N, Rosen, Neal

Journal:

Year:

2002

Language:

english

File:

PDF, 280 KB

english, 2002

21

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Nancy U. Lin, Eric P. Winer, Duncan Wheatley, Lisa A. Carey, Stephen Houston, David Mendelson, Pamela Munster, Laurie Frakes, Steve Kelly, Agustin A. Garcia, Susan Cleator, Martina Uttenreuther-Fische

Journal:

Breast Cancer Research and Treatment

Year:

2012

Language:

english

File:

PDF, 218 KB

english, 2012

22

Identifying Clinically Meaningful Fatigue with the Fatigue Symptom Inventory

Kristine A. Donovan, Paul B. Jacobsen, Brent J. Small, Pamela N. Munster, Michael A. Andrykowski

Journal:

Journal of Pain and Symptom Management

Year:

2008

Language:

english

File:

PDF, 168 KB

english, 2008

23

Histone deacetylase inhibitor induced modulation of anti-estrogen therapy

Scott Thomas, Pamela N. Munster

Journal:

Year:

2009

Language:

english

File:

PDF, 1.25 MB

english, 2009

24

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors

Meredith Bock, Dan Moore, Jimmy Hwang, Dianne Shumay, Laurell Lawson, Deborah Hamolsky, Laura Esserman, Hope Rugo, A. Jo Chien, John Park, Pamela Munster, Michelle Melisko

Journal:

Breast Cancer Research and Treatment

Year:

2012

Language:

english

File:

PDF, 368 KB

english, 2012

25

Development of histone deacetylase inhibitors for cancer treatment

Marchion, Douglas, Münster, Pamela

Journal:

Expert Review of Anticancer Therapy

Year:

2007

Language:

english

File:

PDF, 427 KB

english, 2007

26

Predictive factor for the response to adjuvant therapy with emphasis in breast cancer

Pamela N Munster, Larry Norton

Journal:

Breast Cancer Research

Year:

2001

Language:

english

File:

PDF, 48 KB

english, 2001

27

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

Mahadevan, Daruka, Sutton, Gregory Ryan, Arteta-Bulos, Rafael, Bowden, Chris J., Miller, Paul J. E., Swart, Rachel Elizabeth, Walker, Mark S., Haluska, Paul, Munster, Pamela N., Marshall, John, Hamid,

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2014

Language:

english

File:

PDF, 747 KB

english, 2014

28

ADJUVANT THERAPY FOR RESECTABLE BREAST CANCER

Münster, Pamela N., Hudis, Clifford A.

Journal:

Hematology/Oncology Clinics of North America

Year:

1999

Language:

english

File:

PDF, 1.32 MB

english, 1999

29

Mammalian Cytidine 5′-Monophosphate N-Acetylneuraminic Acid Synthetase: A Nuclear Protein with Evolutionarily Conserved Structural Motifs

Anja-K. Munster, Matthias Eckhardt, Barry Potvin, Martina Muhlenhoff, Pamela Stanley and Rita Gerardy-Schahn

Journal:

Proceedings of the National Academy of Sciences

Year:

1998

Language:

english

File:

PDF, 1.74 MB

english, 1998

30

Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer

Thurn, K Ted, Thomas, Scott, Moore, Amy, Munster, Pamela N

Journal:

Future Oncology

Year:

2011

Language:

english

File:

PDF, 1.41 MB

english, 2011

31

Impact of patient ethnicity on the metabolic and immunologic effects of PI3K–mTOR pathway inhibition in patients with solid tumor malignancies

Aggarwal, Rahul, Grabowsky, Jennifer, Strait, Noah, Cockerill, Alyson, Munster, Pamela

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2014

Language:

english

File:

PDF, 886 KB

english, 2014

32

New protein kinase inhibitors in breast cancer: afatinib and neratinib

Zhang, Xiaosong, Munster, Pamela N

Journal:

Expert Opinion on Pharmacotherapy

Year:

2014

Language:

english

File:

PDF, 332 KB

english, 2014

33

Role of Taxanes in Adjuvant Therapy

Münster, Pamela N., Hudis, Clifford A.

Journal:

Cancer Investigation

Year:

2000

Language:

english

File:

PDF, 634 KB

english, 2000

34

Preclinical and clinical activity of the topoisomerase I inhibitor, karenitecin, in melanoma

Munster, Pamela N, Daud, Adil I

Journal:

Expert Opinion on Investigational Drugs

Year:

2011

Language:

english

File:

PDF, 416 KB

english, 2011

35

Chinese Herbal Formula, Bing De Ling, Enhances Antitumor Effects and Ameliorates Weight Loss Induced by 5-Fluorouracil in the Mouse CT26 Tumor Model

Xu, Qing, Brabham, Jeffrey G., Zhang, Shumin, Munster, Pamela, Fields, Karen, Zhao, Ruan-Jin, Yu, Hua

Journal:

DNA and Cell Biology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

36

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression

Raha, Paromita, Thomas, Scott, Thurn, K, Park, Jeenah, Munster, Pamela N

Journal:

Breast Cancer Research

Year:

2015

Language:

english

File:

PDF, 1.72 MB

english, 2015

37

Estradiol in Breast Cancer Treatment

Munster, Pamela N., Carpenter, John T.

Journal:

JAMA The Journal of the American Medical Association

Year:

2009

Language:

english

File:

PDF, 52 KB

english, 2009

38

Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance

Raha, Paromita, Thomas, Scott, Munster, Pamela N

Journal:

Year:

2011

Language:

english

File:

PDF, 1.44 MB

english, 2011

39

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy

Park, Jeenah, Thomas, Scott, Munster, Pamela N

Journal:

Year:

2015

Language:

english

File:

PDF, 1.32 MB

english, 2015

40

Arzoxifene: the development and clinical outcome of an ideal SERM

Munster, Pamela N

Journal:

Expert Opinion on Investigational Drugs

Year:

2006

Language:

english

File:

PDF, 372 KB

english, 2006

41

SPIE Proceedings [SPIE SPIE Organic Photonics + Electronics - San Diego, California, United States (Sunday 25 August 2013)] Organic Light Emitting Materials and Devices XVII - Novel host materials for blue phosphorescent OLEDs

Strohriegl, Peter, Wagner, Daniel, Schrögel, Pamela, Hoffmann, Sebastian T., Köhler, Anna, Heinemeyer, Ute, Münster, Ingo, So, Franky, Adachi, Chihaya

Year:

2013

Language:

english

File:

PDF, 1.10 MB

english, 2013

42

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma

Homsi, Jade, Cubitt, Christopher L., Zhang, Shumin, Munster, Pamela N., Yu, Hua, Sullivan, Daniel M., Jove, Richard, Messina, Jane L., Daud, Adil I.

Journal:

Melanoma Research

Year:

2009

Language:

english

File:

PDF, 316 KB

english, 2009

43

Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors

Terranova-Barberio, Manuela, Thomas, Scott, Munster, Pamela N

Journal:

Year:

2016

Language:

english

File:

PDF, 1.62 MB

english, 2016

44

Effect of Temporary Ovarian Suppression on Chemotherapy-Induced Amenorrhea, Pregnancy, and Outcome

Munster, Pamela N.

Journal:

Year:

2016

Language:

english

File:

PDF, 98 KB

english, 2016

45

Interest in Initiating an Early Phase Clinical Trial: Results of a Longitudinal Study of Advanced Cancer Patients

Dunn, Laura B., Wiley, Jim, Garrett, Sarah, Hlubocky, Fay, Daugherty, Christopher, Trupin, Laura, Munster, Pamela, Dohan, Daniel

Journal:

Psycho-Oncology

Year:

2016

Language:

english

File:

PDF, 113 KB

english, 2016

46

Utility of a cognitive-behavioral model to predict fatigue following breast cancer treatment.

Donovan, Kristine A., Small, Brent J., Andrykowski, Michael A., Munster, Pamela, Jacobsen, Paul B.

Journal:

Health Psychology

Year:

2007

Language:

english

File:

PDF, 300 KB

english, 2007

47

Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors

Sarantopoulos, John, Goel, Sanjay, Chung, Vincent, Munster, Pamela, Pant, Shubham, Patel, Manish R., Infante, Jeffrey, Tawbi, Hussein, Becerra, Carlos, Bruce, Justine, Kabbinavar, Fairooz, Lockhart, A

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2016

Language:

english

File:

PDF, 480 KB

english, 2016

48

Vascular endothelial growth factor (VEGF) inhibitorsin cancer therapy: an update

Homsi, Jade, Kim, Lori C., Munster, Pamela N., Chodkiewicz, Catherine, Daud, Adil

Journal:

The Women's Oncology Review

Year:

2006

Language:

english

File:

PDF, 528 KB

english, 2006

49

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Lee, Helen, Shields, Anthony F, Siegel, Barry A, Miller, Kathy D., Krop, Ian, Ma, Cynthia X, LoRusso, Patricia M., Munster, Pamela N., Campbell, Karen, Gaddy, Daniel F, Leonard, Shannon C, Geretti, El

Journal:

Clinical Cancer Research

Year:

2017

Language:

english

File:

PDF, 6.57 MB

english, 2017

50

Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial

Guglin, Maya, Munster, Pamela, Fink, Angelina, Krischer, Jeffrey

Journal:

American Heart Journal

Year:

2017

Language:

english

File:

PDF, 540 KB

english, 2017